Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1994;24:220-226

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kumagai, K.
Right arrow Articles by Saruta, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kumagai, K.
Right arrow Articles by Saruta, T.

Hypertension, Vol 24, 220-226, Copyright © 1994 by American Heart Association


ARTICLES

Nitric oxide increases renal blood flow by interacting with the sympathetic nervous system

K Kumagai, H Suzuki, M Ichikawa, M Jimbo, M Murakami, M Ryuzaki and T Saruta
Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan.

To investigate whether changes in renal blood flow induced by nondepressor doses of L-arginine, the precursor of nitric oxide, are mediated by a sympathetic neural mechanism, we examined the following in conscious rabbits: (1) the effects of intravenous infusion of L- or D-arginine (15 to 200 mumol/kg per minute) on renal blood flow and renal sympathetic nerve activity with or without intravenous infusion of a nonpressor dose of NG-monomethyl-L-arginine (L-NMMA), a nitric oxide synthase inhibitor, and (2) the effects of L-arginine on renal blood flow after renal denervation with or without L-NMMA pretreatment. In renal innervated rabbits, L-arginine (100 and 200 mumol/kg per minute) increased renal blood flow by 9 +/- 2 and 16 +/- 3 mL/min (P < .05, respectively) and decreased renal sympathetic nerve activity by 12 +/- 4% and 19 +/- 3% of control (P < .05, respectively). In contrast, no changes occurred in any variable during D-arginine infusion. L-NMMA attenuated the renal blood flow and renal sympathetic nerve activity responses to L-arginine (P < .05). In renal denervated rabbits, L-NMMA also attenuated the renal blood flow responses to L-arginine (P < .05) and abolished them (P < .05) compared with those in renal innervated rabbits. All renal blood flow responses to L-arginine were accompanied by parallel changes in plasma L-citrulline concentration.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
L. E. Spieker, R. Corti, C. Binggeli, T. F. Luscher, and G. Noll
Baroreceptor dysfunction induced by nitric oxide synthase inhibition in humans
J. Am. Coll. Cardiol., July 1, 2000; 36(1): 213 - 218.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. Baylis, J. Harvey, B. R. Santmyire, and K. Engels
Pressor and Renal Vasoconstrictor Responses to Acute Systemic Nitric Oxide Synthesis Inhibition Are Independent of the Sympathetic Nervous System and Angiotensin II
J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 693 - 698.
[Abstract] [Full Text]


Home page
HypertensionHome page
R. Zatz and C. Baylis
Chronic Nitric Oxide Inhibition Model Six Years On
Hypertension, December 1, 1998; 32(6): 958 - 964.
[Full Text] [PDF]


Home page
HypertensionHome page
N. Kurihara, M. E. Alfie, D. H. Sigmon, N.-E. Rhaleb, E. G. Shesely, and O. A. Carretero
Role of nNOS in Blood Pressure Regulation in eNOS Null Mutant Mice
Hypertension, November 1, 1998; 32(5): 856 - 861.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. I. Madrid, M. Garcia-Salom, J. Tornel, M. de Gasparo, and F. J. Fenoy
Interactions Between Nitric Oxide and Angiotensin II on Renal Cortical and Papillary Blood Flow
Hypertension, November 1, 1997; 30(5): 1175 - 1182.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
M. Booke, R. Waurick, H. Van Aken, H.-G. Bone, Andreas Meissner, T. Prien, and J. Meyer
Effects of sympathetic nerve blockade on vasoconstrictive properties of nitric oxide synthase inhibition in sheep
Cardiovasc Res, October 1, 1997; 36(1): 111 - 117.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. Kumagai, H. Suzuki, M. Ichikawa, M. Jimbo, M. Nishizawa, M. Ryuzaki, and T. Saruta
Comparison of Early and Late Start of Antihypertensive Agents and Baroreceptor Reflexes
Hypertension, February 1, 1996; 27(2): 209 - 218.
[Abstract] [Full Text]


Home page
HypertensionHome page
M. Ichikawa, H. Suzuki, K. Kumagai, H. Kumagai, M. Ryuzaki, M. Nishizawa, and T. Saruta
Differential Modulation of Baroreceptor Sensitivity by Long-term Antihypertensive Treatment
Hypertension, September 1, 1995; 26(3): 425 - 431.
[Abstract] [Full Text]


Home page
HypertensionHome page
X. Deng, W. J. Welch, and C. S. Wilcox
Renal Vasodilation With L-Arginine : Effects of Dietary Salt
Hypertension, August 1, 1995; 26(2): 256 - 262.
[Abstract] [Full Text]